Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
U.S. stocks movement: Novartis shares fall more than 2% pre-market as Q1 net sales decline year-on-year for the first time in two years

U.S. stocks movement: Novartis shares fall more than 2% pre-market as Q1 net sales decline year-on-year for the first time in two years

格隆汇格隆汇2026/04/28 09:01
Show original
Golden Finance April 28th | Novartis (NVS.US) fell 2.37% in pre-market trading, at $140.77. According to reports, Novartis' first quarter 2026 profit came in lower than analysts' expectations and sales unexpectedly declined, as some of its best-selling drugs faced intense competition from generics. The financial report shows Novartis’ net sales for the first quarter were $13.113 billion, down 1% year-on-year, marking the first year-on-year decline in nearly two years. Core operating profit fell 12% year-on-year to $4.897 billion, missing analysts’ forecasts of $5.18 billion. Core earnings per share stood at $1.99, down 13% year-on-year. (Golden Finance)
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Wall Street giants such as Goldman Sachs (GS.US) and Morgan Stanley (MS.US) are pressuring law firms to lower fees, aiming to share the efficiency dividends brought by AI.

Goldman Sachs, Morgan Stanley, and Citigroup have informed law firms that, as artificial intelligence (AI) technology has made routine work more efficient, legal fees charged by law firms should also decrease.

智通财经2026/09/01 07:01
Wall Street giants such as Goldman Sachs (GS.US) and Morgan Stanley (MS.US) are pressuring law firms to lower fees, aiming to share the efficiency dividends brought by AI.